홈 › 자궁내막암 › 텍사스

텍사스의 자궁내막암 임상 시험

자궁내막암 관련 연구 95개가 텍사스 내 여러 지역에서 참여자를 모집하고 있습니다.

텍사스의 도시

공식 연구 텍스트(영어)

Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

Parkland Memorial Hospital, Dallas
UT Southwestern/Simmons Cancer Center-Dallas, Dallas
UT Southwestern Clinical Center at Richardson/Plano, Richardson

피험자 모집 중2상

18세 이상 · 여성 · 2026. 11. 12. 업데이트됨 · NCT05112601

A Study to Evaluate OPB-201 in Recurrent Endometrial and Platinum-resistant Ovarian Cancer.

MD Anderson Cancer Center, Houston

피험자 모집 중1상

18세 이상 · 여성 · 2026. 11. 12. 업데이트됨 · NCT07664735

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

NEXT Austin, Austin
START Center for Clinical Research, Fort Worth
University of Texas MD Anderson Cancer Center, Houston
외 2개

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT06270706

A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies

The University of Texas MD Anderson Cancer Center, Houston

피험자 모집 중1상

16세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT07197554

Study of Pelvic Hypofractionated Radiotherapy in Endometrial Cancer

MD Anderson Cancer Center, Houston

피험자 모집 중1/2상

18세 이상 · 여성 · 2026. 11. 12. 업데이트됨 · NCT04683653

A Phase 1 Dose Escalation and Dose Expansion Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation

The University of Texas MD Anderson Cancer Center, Houston
NEXT Oncology, San Antonio

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT07458347

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Hendrick Medical Center, Abilene
UT Southwestern/Simmons Cancer Center-Dallas, Dallas
Lyndon Baines Johnson General Hospital, Houston
외 2개

피험자 모집 중2상

전 연령 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT05564377

Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER

M.D. Anderson Cancer Center, Houston

피험자 모집 중2상

18세 이상 · 여성 · 2026. 11. 12. 업데이트됨 · NCT05640999

A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer

Texas Oncology, P.A., Tyler

피험자 모집 중3상

18세 이상 · 여성 · 2026. 11. 10. 업데이트됨 · NCT06340568

A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

MD Anderson Cancer Center, Houston

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 11. 10. 업데이트됨 · NCT07020221

A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

Texas Oncology - DFW ( Site 8004), Fort Worth
Houston Methodist Hospital ( Site 6057), Houston
Texas Oncology-San Antonio Medical Center ( Site 8001), San Antonio
외 2개

피험자 모집 중3상

18세 이상 · 여성 · 2026. 11. 10. 업데이트됨 · NCT06952504

A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

NEXT Texas LLC - Austin, Austin
START Dallas Fort Worth, LLC, Fort Worth
MD Anderson, Houston
외 4개

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 10. 업데이트됨 · NCT07503808

A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors

SCRI at Mary Crowley, Dallas

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 10. 업데이트됨 · NCT06515613

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

NEXT Oncology, Austin
UT Southwestern, Dallas

피험자 모집 중1상

19세 이상 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT06586957

Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer

Total Women's Care of the Heights, Houston
Medical Colleagues of Texas, LLP, Katy

피험자 모집 중관찰 연구

18세 이상 · 여성 · 2026. 11. 5. 업데이트됨 · NCT05051722

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

USOR Texas Oncology, Abilene
Texas Oncology - Central / South Texas, Austin
Mary Crowley Cancer Research, Dallas
외 3개

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT05579366

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

The University of Texas - MD Anderson Cancer Center, Houston

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06400472

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

Texas Oncology - DFW (Sammons CC), Dallas
MD Anderson Cancer Center, Houston

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT07114601

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

The University of Texas MD Anderson Cancer Center - Texas Medical Center, Houston

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06760819

A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors

Texas Oncology - DFW, Dallas
MD Anderson Cancer Center, Houston

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06695845

Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors

University of Texas Southwestern Medical Center, Dallas

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 3. 업데이트됨 · NCT05856981

Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer

TX Onc - Arlington North, Arlington
USOR - Texas Oncology, Austin
USOR - Texas Oncology, Austin
외 14개

피험자 모집 중3상

18세 이상 · 여성 · 2026. 11. 3. 업데이트됨 · NCT07166094

A Study to Investigate Mocertatug Rezetecan Compared With Chemotherapy in Participants With Endometrial Cancer After Platinum-based Chemotherapy and Immunotherapy (BEHOLD-Endometrial01)

GSK Investigational Site, Sugar Land

피험자 모집 중3상

18세 이상 · 여성 · 2026. 11. 3. 업데이트됨 · NCT07286331

CR-002 in Adult Participants With Locally Advanced or Metastatic Solid Tumors

Clinical Study Site, Austin
Clinical Study Site, Dallas

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 11. 2. 업데이트됨 · NCT07909031

Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors

The University of Texas MD Anderson Cancer Center, Houston
NEXT Houston, Houston
NEXT San Antonio, San Antonio

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 2. 업데이트됨 · NCT07524322

EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors

START Dallas Fort Worth, Fort Worth
University of Texas MD Anderson Cancer Center, Houston

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 10. 30. 업데이트됨 · NCT07262619

Symbiotic-GYN-18: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Advanced or Recurrent MMR-proficient Endometrial Cancer

Texas Oncology - West Texas, Abilene
Texas Oncology-West Texas, Amarillo
Texas Oncology - Central South, Austin
외 13개

피험자 모집 중3상

18세 이상 · 여성 · 2026. 10. 30. 업데이트됨 · NCT07578649

A Phase 1 Study of LNCB74 in Advanced Solid Tumors

MD Anderson, Houston
UT Health San Antonio - MD Anderson Cancer Center, San Antonio

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 10. 29. 업데이트됨 · NCT06774963

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

MD Anderson Cancer Center, Houston
START Center for Cancer Research, San Antonio

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 10. 28. 업데이트됨 · NCT07109726

A Study of MGC026 in Participants With Advanced Solid Tumors

The University of Texas MD Anderson Cancer Center, Houston
University of Texas Health Science Center at Houston, Houston

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 10. 28. 업데이트됨 · NCT06242470

A Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer in Adjuvant Setting

Texas Oncology - Bedford, Bedford
Texas Oncology San Antonio Medical Center, San Antonio

피험자 모집 중3상

18세 이상 · 여성 · 2026. 10. 27. 업데이트됨 · NCT07022483

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

Texas Oncology - West Texas, Amarillo
Texas Oncology, P.A., Dallas
Texas Oncology Gulf Coast, Pearland

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 10. 26. 업데이트됨 · NCT06330064

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

The University of Texas MD Anderson Cancer Center, Houston

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 10. 26. 업데이트됨 · NCT06172478

Phase 1 Study of STRO-006 in Adults With Refractory Solid Tumors That Are Recurrent or Metastatic

NEXT Oncology Dallas, Irving
Texas Tech University Health Sciences Center, Lubbock

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 10. 23. 업데이트됨 · NCT07807345

A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors

NEXT Austin, Austin

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 10. 22. 업데이트됨 · NCT07383506

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

Mary Crowley Cancer Research, Dallas
University of Texas Southwestern, Dallas

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 10. 22. 업데이트됨 · NCT04657068

Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

MD Anderson Cancer Center, Houston
NEXT Oncology, San Antonio

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 10. 15. 업데이트됨 · NCT06239194

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

Start - Dfw, Fort Worth
Oncology Consultants, Houston
START - San Antonio, San Antonio

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 10. 13. 업데이트됨 · NCT06293898

A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies

Research Site, Houston

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 10. 13. 업데이트됨 · NCT05123482

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

Research Site, Austin
Research Site, Fort Worth
Research Site, Houston
외 1개

피험자 모집 중3상

18세 이상 · 여성 · 2026. 10. 13. 업데이트됨 · NCT06989112

ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.